ZT002, a novel ultra long-acting GLP-1 receptor agonist in adults with overweight or obesity: a randomised, placebo-controlled, multiple ascending dose phase 1c study

ZT002 - Beijing QL Biopharma

L. Ji1; H. Zhou2; X. Li2; X. Xu3; A. Wong3; Y. Zu3; X. Song3; Y. Zhang3; S. Lin3; X. Zhang3; Y. Zhang3

Jul 2, 2024